NFKB1 and Alzheimer disease: A previous study [40] showed NFkB as a treatment target for AD, because when silenced by p65 knockdown it reduced activated microglial gene expression and morphology, however, recent spatial transcriptomics analysis by Welch et al. [11] further revealed that NFkB knockdown played a similar pivotal role in DSB-bearing neurons.